Key facts
- Notable investors include Tech Incubator Program for Startup, SK Impact Fund, BNK Venture Capital, Sema Investment, Sopoong.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Dr. True
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr. True are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr. True
Operator of a food and beverage brand intended to promote healthier lifestyles by reducing sugar consumption. The company offers low-calorie sweeteners, fruit-based products, and beverages that preserve natural flavors, enabling health-conscious consumers to enjoy sweetness without compromising well-being.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Chuncheon, South Korea
- Founded
- 2021
- Employees
- 9
- Website
- drtrue.kr/
- Ownership
- Privately Held (backing)
Dr. True doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr. True shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr. True in its N-PORT filings yet. We sweep new filings monthly.